Castle Creek Pharmaceuticals Announces Data Validating First Investigator’s Global Assessment Scale for Epidermolysis Bullosa Simplex Clinical Research

January 15, 2018

Responsive image

PARSIPPANY, N.J., Jan. 15, 2018 /PRNewswire/ — Castle Creek Pharmaceuticals (CCP), a global biotech company dedicated to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, today announced that data from an evaluation of a completed…

Category: Precious Metals